Local cardiac responses--alternative methods of control

B Maisch1

  • 1Phillipps-University Marburg, Department of Internal Medicine and Cardiology, Federal Republic of Germany.

Insights

Beyond beta-adrenoceptors, other cardiac mechanisms like the Frank-Starling mechanism and parasympathetic influence are crucial for heart function and heart failure management. Understanding these factors improves treatment strategies.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Cardiac function is heavily influenced by the beta-adrenoceptor system, particularly in heart failure.
  • While beta-1 receptors are well-studied, other mechanisms like the Frank-Starling mechanism and autonomic nervous system also play significant roles.

Purpose of the Study:

  • To highlight the importance of non-beta-adrenoceptor cardiac control mechanisms in normal and failing hearts.
  • To emphasize the clinical relevance of these mechanisms in heart failure treatment.

Main Methods:

  • Review of existing literature on cardiac physiology and pharmacology.
  • Analysis of the roles of mechanical stretching (Frank-Starling), atrial receptors, and autonomic nervous system (parasympathetic and sympathetic) in cardiac function.

Main Results:

  • The Frank-Starling mechanism is critical for understanding preload manipulation effects in heart failure.
  • Atrial natriuretic factor release and parasympathetic (vagal) influence on heart rate are significant compensatory responses.
  • Cardiac receptors beyond beta-1, including alpha-1 and alpha-2 adrenoceptors, and local hormones also modulate cardiac function.

Conclusions:

  • A comprehensive understanding of cardiac function requires considering multiple control systems beyond beta-adrenoceptors.
  • These mechanisms are vital for effective management of heart failure and related cardiovascular conditions.

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...